PFIZER INC Long-Term Concentrated

Location: New York, NY

CIK: 0000078003 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 13, 2025

Total Value: $501M (100.0% shares, 0.0% debt)

Holdings (21)

BNTX BIONTECH SE 66.5%
Value $333M Shares 3,658,361 Est. Cost $113.95 Unrealized
ALLO ALLOGENE THERAPEUTICS INC 6.4%
Value $32.17M Shares 22,032,040 Est. Cost $2.47 Unrealized -23.6%
ORIC ORIC PHARMACEUTICALS INC 6.0%
Value $30M Shares 5,376,344 Est. Cost $9.18 Unrealized -4.7%
ARVN ARVINAS INC 4.8%
Value $24.27M Shares 3,457,815 Est. Cost $24.30 Unrealized -35.5%
TOURMALINE BIO INC 3.9%
Value $19.35M Shares 1,272,214 Est. Cost $20.28 Unrealized
WVE WAVE LIFE SCIENCES LTD 3.0%
Value $15.15M Shares 1,875,000 Est. Cost $13.35 Unrealized -18.1%
BHVN BIOHAVEN LTD 2.4%
Value $12.16M Shares 505,645 Est. Cost $46.66 Unrealized -24.4%
CRDF CARDIFF ONCOLOGY INC 1.5%
Value $7.572M Shares 2,411,575 Est. Cost $3.13 Unrealized +26.5%
PYXS PYXIS ONCOLOGY INC 1.4%
Value $6.891M Shares 7,032,770 Est. Cost $2.88 Unrealized -53.7%
CRBU CARIBOU BIOSCIENCES INC 0.9%
Value $4.283M Shares 4,690,431 Est. Cost $2.01 Unrealized -35.4%
ZURA ZURA BIO LTD 0.8%
Value $3.831M Shares 2,970,022 Est. Cost $3.56 Unrealized -55.7%
CELC CELCUITY INC 0.7%
Value $3.532M Shares 349,406 Est. Cost $14.11 Unrealized -19.8%
ESSA PHARMA INC 0.5%
Value $2.647M Shares 1,675,000 Est. Cost $1.79 Unrealized
SPRO SPERO THERAPEUTICS INC 0.3%
Value $1.701M Shares 2,362,348 Est. Cost $1.19 Unrealized -29.0%
ZNTL ZENTALIS PHARMACEUTICALS INC 0.3%
Value $1.517M Shares 953,834 Est. Cost $3.28 Unrealized -34.2%
ANTX AN2 THERAPEUTICS INC 0.2%
Value $973K Shares 715,295 Est. Cost $1.21 Unrealized +3.8%
NEXTCURE INC 0.2%
Value $909K Shares 1,891,763 Est. Cost $1.11 Unrealized
QTTB Q32 BIO INC 0.1%
Value $458K Shares 277,777 Est. Cost $31.58 Unrealized -91.5%
BOLT BIOTHERAPEUTICS INC 0.1%
Value $250K Shares 626,109 Est. Cost $0.54 Unrealized
SENSEONICS HLDGS INC 0.0%
Value $28,492 Shares 43,426 Est. Cost $0.52 Unrealized
DNA GINKGO BIOWORKS HOLDINGS INC 0.0%
Value $16,690 Shares 2,928 Est. Cost $8.57 Unrealized +18.9%